Scilex Holding Company Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
Scilex Holding Company (SCLX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 29.00 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2026-08-14
- Scilex Holding Company share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-06-30 was 19.00K shares, a 46.15% increase year-over-year.
- Scilex Holding Company share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-03-31 was 10.00K shares, a 66.67% increase year-over-year.
- Scilex Holding Company share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-12-31 was -29.67K shares.
- Scilex Holding Company share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-09-30 was 11.00K shares, a 96.90% decline year-over-year.
- Scilex Holding Company share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2025 was 327.00 shares, a 78.20% decline from fiscal 2024.
- Scilex Holding Company share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2024 was 1.50K shares, a 41.51% increase from fiscal 2023.
- Scilex Holding Company share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2023 was 1.06K shares, a 99.94% decline from fiscal 2022.
- Scilex Holding Company share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2022 was 1.83M shares, a 2.76% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 19.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | 29.00K shares 10-Q · filed 2026-08-14 | -673.00 shares derived: sum of 3 quarters · filed 2026-08-14 | 10.33K shares derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | 10.00K shares 10-Q · filed 2026-05-20 | -19.67K shares derived: sum of 2 quarters · filed 2026-05-20 | -8.67K shares derived: sum of 3 quarters · filed 2026-05-20 | 4.33K shares derived: sum of 4 quarters · filed 2026-05-20 |
| 2025-12-31 | -29.67K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-10 | -18.67K shares derived: sum of 2 quarters · filed 2026-04-10 | -5.67K shares derived: sum of 3 quarters · filed 2026-04-10 | 327.00 shares 10-K · filed 2026-04-10 |
| 2025-09-30 | 11.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | 24.00K shares derived: sum of 2 quarters · filed 2025-11-14 | 30.00K shares 10-Q · filed 2025-11-14 | -444.50K shares derived: sum of 4 quarters · filed 2025-11-14 |
| 2025-06-30 | 13.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | 19.00K shares 10-Q · filed 2025-08-13 | -455.50K shares derived: sum of 3 quarters · filed 2025-08-13 | -100.50K shares derived: sum of 4 quarters · filed 2025-08-13 |
| 2025-03-31 | 6.00K shares 10-Q · filed 2025-05-14 | -468.50K shares derived: sum of 2 quarters · filed 2025-05-14 | -113.50K shares derived: sum of 3 quarters · filed 2025-05-14 | 7.45K shares derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-12-31 | -474.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -119.50K shares derived: sum of 2 quarters · filed 2025-03-31 | 1.45K shares derived: sum of 3 quarters · filed 2025-03-31 | 1.50K shares 10-K · filed 2025-03-31 |
| 2024-09-30 | 355.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-01-17 | 475.95K shares derived: sum of 2 quarters · filed 2025-01-17 | 476.00K shares 10-Q · filed 2025-01-17 | 476.31K shares derived: sum of 4 quarters · filed 2025-01-17 |
| 2024-06-30 | 120.95K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 121.00K shares 10-Q · filed 2024-08-13 | 121.31K shares derived: sum of 3 quarters · filed 2024-08-13 | 121.78K shares derived: sum of 4 quarters · filed 2024-08-13 |
| 2024-03-31 | 51.00 shares 10-Q · filed 2024-05-13 | 358.00 shares derived: sum of 2 quarters · filed 2024-05-13 | 833.00 shares derived: sum of 3 quarters · filed 2024-05-13 | 1.10K shares derived: sum of 4 quarters · filed 2024-05-13 |
| 2023-12-31 | 307.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | 782.00 shares derived: sum of 2 quarters · filed 2024-03-12 | 1.05K shares derived: sum of 3 quarters · filed 2024-03-12 | 1.06K shares 10-K · filed 2024-03-12 |
| 2023-09-30 | 475.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | 745.00 shares derived: sum of 2 quarters · filed 2023-11-14 | 753.00 shares 10-Q · filed 2023-11-14 | |
| 2023-06-30 | 270.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | 278.00 shares 10-Q · filed 2023-08-11 | ||
| 2023-03-31 | 8.00 shares 10-Q · filed 2023-05-12 | |||
| 2022-12-31 | 1.83M shares 10-K · filed 2023-03-07 | |||
| 2021-12-31 | 1.78M shares 10-K · filed 2023-03-07 | |||
| 2020-12-31 | 502.00K shares 10-K · filed 2023-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |